Catawba River Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.6M | Buy |
29,676
+20,006
| +207% | +$10.5M | 7.92% | 4 |
|
|
2025
Q1 | $6.13M | Buy |
9,670
+391
| +4% | +$248K | 3.73% | 13 |
|
|
2024
Q4 | $6.61M | Buy |
9,279
+383
| +4% | +$273K | 3.94% | 13 |
|
|
2024
Q3 | $9.35M | Buy |
8,896
+27
| +0.3% | +$28.4K | 5.91% | 6 |
|
|
2024
Q2 | $9.32M | Sell |
8,869
-7,184
| -45% | -$7.55M | 5.64% | 5 |
|
|
2024
Q1 | $15.5M | Sell |
16,053
-136
| -0.8% | -$131K | 9% | 2 |
|
|
2023
Q4 | $14.2M | Buy |
16,189
+202
| +1% | +$177K | 9.99% | 2 |
|
|
2023
Q3 | $13.2M | Buy |
15,987
+14
| +0.1% | +$11.5K | 10.14% | 2 |
|
|
2023
Q2 | $11.5M | Buy |
15,973
+6,721
| +73% | +$4.83M | 9.15% | 2 |
|
|
2023
Q1 | $7.6M | Sell |
9,252
-3
| -0% | -$2.47K | 6.91% | 2 |
|
|
2022
Q4 | $6.68M | Sell |
9,255
-8
| -0.1% | -$5.77K | 7% | 5 |
|
|
2022
Q3 | $6.38M | Buy |
9,263
+85
| +0.9% | +$58.6K | 7.6% | 3 |
|
|
2022
Q2 | $5.43M | Buy |
9,178
+215
| +2% | +$127K | 7.13% | 6 |
|
|
2022
Q1 | $6.26M | Buy |
8,963
+11
| +0.1% | +$7.68K | 4.15% | 11 |
|
|
2021
Q4 | $5.65M | Buy |
8,952
+184
| +2% | +$116K | 3.43% | 18 |
|
|
2021
Q3 | $5.31M | Buy |
+8,768
| New | +$5.31M | 3.34% | 19 |
|